Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引：0
|
作者：
Markus Luster
Martin Schlumberger
Furio Pacini
机构：
[1] University of Ulm,Department of Nuclear Medicine
[2] Institut Gustave Rousy,Department of Nuclear Medicine and Endocrine Oncology
[3] University of Siena,Department of Internal Medicine, Section of Endocrinology & Metabolism
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2009年 / 36卷
关键词：
Thyroid Cancer; Hypothyroidism; Thyroglobulin; Differentiate Thyroid Cancer; Serum Thyroglobulin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 330
页数：1
相关论文
共 50 条
  • [1] Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective
    Paolo Zanotti-Fregonara
    Domenico Rubello
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1397 - 1399
  • [2] Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer
    Pacini, Furio
    Castagna, Maria Grazia
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (06) : 1009 - 1021
  • [3] Radioiodine Therapy in Differentiated Thyroid Cancer: a Nuclear Medicine Perspective
    Clarke, S. E. M.
    CLINICAL ONCOLOGY, 2010, 22 (06) : 430 - 437
  • [4] Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH
    Sugino, Kimintori
    Ito, Koichi
    Takami, Hiroshi
    ENDOCRINE JOURNAL, 2006, 53 (06) : 723 - 728
  • [5] Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
    Ha, Jeonghoon
    Kim, Min Hee
    Jo, Kwanhoon
    Lim, Yejee
    Bae, Ja Seong
    Lee, Sohee
    Kang, Moo Il
    Cha, Bong Yun
    Lim, Dong Jun
    MEDICINE, 2017, 96 (29)
  • [6] Nuclear medicine impact on differentiated thyroid cancer diagnosis and treatment
    Medina-Ornelas, Sevastian
    Garcia-Perez, Francisco
    Granados-Garcia, Martin
    GACETA MEDICA DE MEXICO, 2018, 154 (04): : 509 - 519
  • [7] Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
    Jeong, Eugene
    Yoon, Joon-Kee
    Lee, Su Jin
    Soh, Euy Young
    Lee, Jeonghun
    Kim, Hyeung Kyoo
    An, Young-Sil
    MEDICINE, 2019, 98 (51)
  • [8] On the effectiveness of recombinant human TSH as a stimulating agent for 131I treatment of metastatic differentiated thyroid cancer
    Paolo Zanotti-Fregonara
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 2264 - 2266
  • [9] Nuclear Medicine Imaging in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-I
    Oh, So Won
    Park, Sohyun
    Chong, Ari
    Kim, Keunyoung
    Bang, Ji-In
    Seo, Youngduk
    Hong, Chae Moon
    Lee, Sang-Woo
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 1 - 7
  • [10] Radioactive Iodine Therapy in Differentiated Thyroid Cancer: Summary of the Korean Thyroid Association Guidelines 2024 from Nuclear Medicine Perspective, Part-II
    Oh, So Won
    Park, Sohyun
    Chong, Ari
    Kim, Keunyoung
    Bang, Ji-In
    Seo, Youngduk
    Hong, Chae Moon
    Lee, Sang-Woo
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, 59 (01) : 8 - 26
12345